packageParsaclisib

parsaclisib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Parsaclisib is an investigational PI3K inhibitor anticancer drug. Its marketing application in the European Union was withdrawn, so it is not authorised there.

Summary written by glm-5.3-flash from Wikidata Q76802661 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:parsaclisib
ATC codes:L01EM05
DrugBank:DB14867
PubChem CID:86677874
Wikidata:Q76802661
formula:C20H22ClFN6O2
molar mass:432.884 g/mol (PubChem CID 86677874)
logP:2.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown